Clinical Trial Update: Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on autologous CAR-T/TCR-T cell therapy for solid malignancies across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagus Cancer
• Gastric Cancer
• Glioma
• Hepatocellular Carcinoma

Drugs mentioned

• Autologous CAR-T/TCR-T cell therapy (investigational)

Snippet

Sponsor: Shenzhen BinDeBio Ltd. | Conditions: Esophagus Cancer, Hepatoma | Phase 1, Phase 2 | Status: UNKNOWN